| Cover - shares | 6 Months Ended | |
| Apr. 30, 2021 | Jun. 11, 2021 | |
| Cover [Abstract] | ||
| Entity Registrant Name | HUAIZHONG HEALTH GROUP, INC. | |
| Entity Central Index Key | 0001593204 | |
| Document Type | 10-Q | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --10-31 | |
| Entity Small Business | true | |
| Entity Shell Company | true | |
| Entity Emerging Growth Company | true | |
| Entity Current Reporting Status | Yes | |
| Document Period End Date | Apr. 30, 2021 | |
| Entity Filer Category | Non-accelerated Filer | |
| Document Fiscal Period Focus | Q2 | |
| Document Fiscal Year Focus | 2021 | |
| Entity Ex Transition Period | false | |
| Entity Common Stock Shares Outstanding | 31,518,466 | |
| Document Quarterly Report | true | |
| Document Transition Report | false | |
| Entity File Number | 000-55369 | |
| Entity Incorporation State Country Code | NV | |
| Entity Tax Identification Number | 90-1020141 | |
| Entity Address Address Line 1 | Tianan Technology Park | |
| Entity Address Address Line 2 | 13/F Headquarters Center Building 16 | |
| Entity Address Address Line 3 | 555 Panyu North Ave | |
| Entity Address City Or Town | Guangzhou City | |
| Entity Address Country | CN | |
| City Area Code | 86 | |
| Local Phone Number | 2982 9356 | |
| Entity Interactive Data Current | Yes |
| Balance Sheets - USD ($) | Apr. 30, 2021 | Oct. 31, 2020 |
| Current Assets | ||
| Cash | $ 0 | $ 0 |
| Total Current Assets | 0 | 0 |
| Total Assets | 0 | 0 |
| Current Liabilities | ||
| Accounts payable | 14,474 | 10,913 |
| Due to related party | 28,542 | 8,559 |
| Total Current Liabilities | 43,016 | 19,472 |
| Total Liabilities | 43,016 | 19,472 |
| Stockholders' Deficit | ||
| Common stock: 750,000,000 shares authorized; $0.001 par value 31,518,466 issued and outstanding at April 30, 2021 and October 31, 2020 | 31,518 | 31,518 |
| Additional paid in capital | 257,587 | 257,587 |
| Accumulated deficit | (332,121) | (308,577) |
| Total Stockholders' Deficit | (43,016) | (19,472) |
| Total Liabilities and Stockholders' Deficit | $ 0 | $ 0 |
| Balance Sheets (Parenthetical) - $ / shares | Apr. 30, 2021 | Oct. 31, 2020 |
| STOCKHOLDERS' EQUITY (DEFECIENCY) | ||
| Common stock, par value | $ 0.001 | $ 0.001 |
| Common stock shares authorized | 750,000,000 | 750,000,000 |
| Common stock shares issued | 31,518,466 | 31,518,466 |
| Common stock shares outstanding | 31,518,466 | 31,518,466 |
| Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
| Apr. 30, 2021 | Apr. 30, 2020 | Apr. 30, 2021 | Apr. 30, 2020 | |
| Statements of Operations (Unaudited) | ||||
| Revenue | $ 0 | $ 0 | $ 0 | $ 0 |
| Operating Expenses | ||||
| Professional fees | 11,959 | 0 | 21,569 | 0 |
| General and administrative | 300 | 6,304 | 1,975 | 11,622 |
| Total Operating Expenses | 12,259 | 6,304 | 23,544 | 11,622 |
| Operating Loss | (12,259) | (6,304) | (23,544) | (11,622) |
| Other Income (Expense) | ||||
| Interest expense | 0 | (154) | 0 | (269) |
| Total Other Expense | 0 | (154) | 0 | (269) |
| Net Loss | $ (12,259) | $ (6,458) | $ (23,544) | $ (11,891) |
| Net loss per common share, basic and diluted | $ 0 | $ (0.01) | $ 0 | $ (0.02) |
| Basic and diluted weighted average common shares outstanding | 31,518,466 | 517,853 | 31,518,466 | 517,853 |
| Statements of Changes in Stockholders Deficit (Unaudited) - USD ($) | Total | Common Stock | Additional Paid-In Capital | Accumulated Deficit |
| Balance, shares at Oct. 31, 2019 | 517,853 | |||
| Balance, amount at Oct. 31, 2019 | $ (21,097) | $ 518 | $ 250,482 | $ (272,097) |
| Net loss | (5,433) | $ 0 | 0 | (5,433) |
| Balance, shares at Jan. 31, 2020 | 517,853 | |||
| Balance, amount at Jan. 31, 2020 | (26,530) | $ 518 | 250,482 | (277,530) |
| Balance, shares at Oct. 31, 2019 | 517,853 | |||
| Balance, amount at Oct. 31, 2019 | (21,097) | $ 518 | 250,482 | (272,097) |
| Net loss | (11,891) | |||
| Balance, shares at Apr. 30, 2020 | 517,853 | |||
| Balance, amount at Apr. 30, 2020 | (32,988) | $ 518 | 250,482 | (283,988) |
| Balance, shares at Jan. 31, 2020 | 517,853 | |||
| Balance, amount at Jan. 31, 2020 | (26,530) | $ 518 | 250,482 | (277,530) |
| Net loss | (6,458) | $ 0 | 0 | (6,458) |
| Balance, shares at Apr. 30, 2020 | 517,853 | |||
| Balance, amount at Apr. 30, 2020 | (32,988) | $ 518 | 250,482 | (283,988) |
| Balance, shares at Oct. 31, 2020 | 31,518,466 | |||
| Balance, amount at Oct. 31, 2020 | (19,472) | $ 31,518 | 257,587 | (308,577) |
| Net loss | (11,285) | $ 0 | 0 | (11,285) |
| Balance, shares at Jan. 31, 2021 | 31,518,466 | |||
| Balance, amount at Jan. 31, 2021 | (30,757) | $ 31,518 | 257,587 | (319,862) |
| Balance, shares at Oct. 31, 2020 | 31,518,466 | |||
| Balance, amount at Oct. 31, 2020 | (19,472) | $ 31,518 | 257,587 | (308,577) |
| Net loss | (23,544) | |||
| Balance, shares at Apr. 30, 2021 | 31,518,466 | |||
| Balance, amount at Apr. 30, 2021 | (43,016) | $ 31,518 | 257,587 | (332,121) |
| Balance, shares at Jan. 31, 2021 | 31,518,466 | |||
| Balance, amount at Jan. 31, 2021 | (30,757) | $ 31,518 | 257,587 | (319,862) |
| Net loss | (12,259) | $ 0 | 0 | (12,259) |
| Balance, shares at Apr. 30, 2021 | 31,518,466 | |||
| Balance, amount at Apr. 30, 2021 | $ (43,016) | $ 31,518 | $ 257,587 | $ (332,121) |
| Statements of Cash Flows (Unaudited) - USD ($) | 6 Months Ended | |
| Apr. 30, 2021 | Apr. 30, 2020 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net loss | $ (23,544) | $ (11,891) |
| Changes in current assets and liabilities: | ||
| Related party advances funding operations | 19,983 | 10,730 |
| Prepaid expenses | 0 | (750) |
| Accounts payable | 3,561 | 1,911 |
| Net cash used in operating activities | 0 | 0 |
| Net change in cash for the period | 0 | 0 |
| Cash at beginning of period | 0 | 0 |
| Cash at end of period | 0 | 0 |
| SUPPLEMENTAL CASH FLOW INFORMATION: | ||
| Cash paid for income taxes | 0 | 0 |
| Cash paid for interest | $ 0 | $ 0 |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 6 Months Ended |
| Apr. 30, 2021 | |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
| NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation of Unaudited Interim Financial Statements The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended October 31, 2020, as filed with the SEC on March 22, 2021. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments. A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at April 30, 2021. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to develop its business plan. Reclassification Certain accounts from prior periods have been reclassified to conform to the current period presentation. |
| GOING CONCERN | 6 Months Ended |
| Apr. 30, 2021 | |
| GOING CONCERN | |
| NOTE 2 - GOING CONCERN | NOTE 2 - GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of April 30, 2021, the Company has suffered recurring losses from operations, has an accumulated deficit of $332,121 and has not earned any revenues. The Company intends to fund operations through equity financing arrangements and related party advances, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending October 31, 2021. The ability of the Company to emerge from an early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty |
| RELATED PARTY TRANSACTIONS | 6 Months Ended |
| Apr. 30, 2021 | |
| RELATED PARTY TRANSACTIONS | |
| NOTE 3 - RELATED PARTY TRANSACTIONS | NOTE 3 - RELATED PARTY TRANSACTIONS During the six months ended April 30, 2021, the Company’s sole officer advanced to the Company an amount of $19,983 by paying for expenses on behalf of the Company. As of April 30, 2021, and October 31, 2020, the Company was obligated to the officer, for an unsecured, non-interest-bearing demand loan with a balance of $28,542 and $8,559, respectively. Other The Company does not own or lease property or lease office space. The office space used by the Company was arranged by the CEO and President, of the Company to use at no charge. |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 6 Months Ended |
| Apr. 30, 2021 | |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
| Basis of Presentation of Unaudited Interim Financial Statements | The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended October 31, 2020, as filed with the SEC on March 22, 2021. |
| Use of Estimates | The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments. A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and in markets served. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at April 30, 2021. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to develop its business plan. |
| Reclassification | Certain accounts from prior periods have been reclassified to conform to the current period presentation. |
| GOING CONCERN (Details Narrative) - USD ($) | Apr. 30, 2021 | Oct. 31, 2020 |
| GOING CONCERN (Details Narrative) | ||
| Accumulated deficit | $ (332,121) | $ (308,577) |
| RELATED PARTY TRANSACTIONS (Details Narrative) - Sole Officer [Member] - USD ($) | 6 Months Ended | |
| Apr. 30, 2021 | Oct. 31, 2020 | |
| Expenses paid on the behalf of company | $ 19,983 | |
| Non-interest-bearing demand loan | $ 28,542 | $ 8,559 |
